Ads
related to: Sanofi SA
Search results
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional...
Benzinga via Yahoo Finance· 1 year agoInnate Pharma SA (NASDAQ: IPHA) and Sanofi SA (NASDAQ: SNY) have expanded their collaboration, with...
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) elected to terminate its second amended and restated collaboration and...
Sanofi to let go of staff at vaccine plants in India as part of review
Reuters via Yahoo Finance· 1 year agoFrench drugmaker Sanofi SA is reviewing operations at two of its vaccine making facilities in India...
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Benzinga via Yahoo Finance· 1 year agoAfter Sanofi SA (NASDAQ: SNY) failed to secure a UNICEF contract, the company is weighing closing...
FDA Approves Sanofi's Hemophilia A Therapy Offering Significant Bleed Protection
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Sanofi SA's (NASDAQ: SNY) Altuviiio, previously referred to as efanesoctocog alfa,...
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said that uninsured diabetes patients in the U.S. will pay no more than $35...
Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech
Benzinga via Yahoo Finance· 1 year agoFrench pharma major Sanofi SA (NASDAQ: SNY) entered into a collaboration and licensing agreement...
Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the...
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
Benzinga via Yahoo Finance· 2 years agoSoon after the European Commission's (EC) approval, Sanofi SA (NASDAQ: SNY) scooped up the FDA's OK...